Crown Aesthetics, a division of Crown Laboratories and the global leader in microneedling technology, is proud to share that SkinPen Precision was named "Best in Industry – Nonsurgical Innovation" in the Aesthetic Awards. Presented by The Aesthetic Guide, the Aesthetic Awards shine a spotlight on product manufacturers and practice management companies that are shaping the future of aesthetic medicine.

SkinPen is the first FDA-cleared microneedling device on the market, with over two million treatments performed worldwide. It is the device of choice for aesthetic practices, as it stimulates the body's natural wound healing process which triggers the immune system to remodel the scar tissue. In SkinPen's clinical trials, 90% of patients reported an improvement in the appearance of their acne scars at the end of six months and would recommend this procedure to friends and family.

"We're thrilled to receive this honor from the esteemed group of professionals at The Aesthetic Guide," says Michael McKenna, General Manager & Executive Vice President of Crown Aesthetics. "We strive to offer best-in-class medical technologies like SkinPen Precision, the first FDA-cleared microneedling device on the market, and to have those efforts recognized by our peers and colleagues is a testament to Crown Aesthetics' dedication to efficacy and safety."

SkinPen is backed by 90+ validation studies to ensure quality, safety, and performance. The U.S.A. engineered and manufactured device has set the standard in the microneedling industry with an unyielding pursuit to deliver therapeutic excellence and enhanced patient outcomes. For more information, please visit https://skinpen.com/.

Read more at PR Newswire >>